Clinical Trial Update: Long-Term Follow-Up Study of HIV-1 Infected Adults Who Received EBT-101 [Phase 1]

View source ↗

Summary

The update describes the Phase 1 long-term follow-up study of HIV infection in adults who received EBT-101, with enrollment by invitation continuing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• EBT-101

Snippet

Sponsor: Excision BioTherapeutics | Conditions: HIV-1-infection | Phase 1 | Status: ENROLLING_BY_INVITATION